FORM 8.3
DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE
(Rule 8.3 of the City Code on Takeovers and Mergers)
1. KEY INFORMATION
Name of person dealing (Note BARCLAYS PLC
1)
Company dealt in MORGAN CRUCIBLE CO
Class of relevant security ORD GBP 0.25
to which the dealings being
disclosed relate (Note 2)
Date of dealing 07 August 2006
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
(1) Relevant 7,393,702 2.52% 64,072 0.02%
securities
(2) Derivatives 64,072 0.02% 443,185 0.15%
(other than
options)
(3) Options and 0 0.00% 0 0.00%
agreements to
purchase/sell
Total 7,457,774 2.54% 507,257 0.17%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than
options)
(3) Options and agreements
to purchase/sell
Total
(c) Rights to subscribe (Note 3)
Class of relevant security: Details
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit (GBP)
Sale 2,200 2.3322
Sale 2,950 2.4161
Sale 4,073 2.4865
Sale 14,200 2.3705
Purchase 2,073 2.5041
These transactions have taken place as a consequence of transactions in respect
of BGI's passive investment management and/or index funds. The Panel Executive
has informed BGI, on an ex parte basis, that such transactions are permitted and
have no Code consequences.
(b) Derivatives transactions (other than options)
Product Long/short Number of securities Price per unit
CFD Short 2200 2.3322
CFD Short 14200 2.3705
CFD Short 2950 2.416
CFD Short 4073 2.4865
CFD Long 2073 2.504
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, Number of Exercise Type, e.g. Expiry Option money
e.g. call selling, securities to price American, date paid/received
option purchasing, which the option European etc. per unit (Note 5)
varying etc. relates (Note 7)
(ii) Exercising
Product name, e.g. call Number of securities Exercise price per unit
option (Note 5)
(d) Other dealings (including new securities) (Note 4)
Nature of transaction Details Price per unit (if
(Note 8) applicable) (Note 5)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the
person disclosing and any other person relating to the voting rights of
any relevant securities under any option referred to on this form or
relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is
referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 08 August 2006
Contact name BARCLAYS COMPLIANCE
Telephone number 020 7166 2913
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.